ascopubs.org

BCR-ABL mutation testing in patients with CML occurrence prior to a 10X rise in BCR-ABL test results.

Oncoguide System: A computerized interactive assistance system for the diagnosis and treatment of CML/MPN and MDS D. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
Nature

Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients

Freshly collected or frozen bone marrow or peripheral blood samples were obtained from the patients in accordance to the Declaration of Helsinki. All participants of the EuroFlow Consortium (EU-FP6 ...
Medical News Today

Genetic testing for CML: Types and how they work

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...
ascopubs.org

Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia

Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up A total of 962 cases of CML on ...
FierceBiotech

MolecularMD and ARIAD Announce Voluntary Withdrawal Of MolecularMD’s Premarket Approval Application For BCR-ABL T315I Mutation Test

ARIAD Pharmaceuticals, Inc.Kendra Adams, 617-503-7028orLiza Heapes, 617-621-2315orKatherine Clock, 503-459-4974 and (NASDAQ: ARIA) today announced that MolecularMD has voluntarily withdrawn its ...